B. Braun Melsungen AG:企業の戦略的SWOT分析

◆英語タイトル:B. Braun Melsungen AG - Strategic SWOT Analysis Review
◆商品コード:GDME219SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

B. Braun Melsungen AG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

B. Braun Melsungen AG (B. Braun) develops, manufactures and distributes medical technology and pharmaceutical products and provides medical services. The company’s major products include solutions and consumables for infusion, disinfection products, infusion pumps and systems, nutrition and pain therapy, suture materials, hip and knee implants, surgical instruments, dialysis equipment and accessories, ostomy care and wound care products. B. Braun provides products and systems in the fields of anesthesia, extracorporeal blood treatment, intensive care, cardiology, and surgery. It also offers services for clinics, physician practices, and the home care segment. The company sells products in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.

B. Braun Melsungen AG Key Recent Developments

Feb 16,2021: Vaccination Supplies: Warning against Fraud Attempts with Supposed B. Braun Products
Jun 05,2020: After more than 30 years of service, Management Board Member Caroll H. Neubauer Retires from B. Braun
May 14,2020: Aesculap wins iF DESIGN AWARD
Apr 04,2020: Scam alert for sale of B. Braun products
Mar 27,2020: 2019 fiscal year: B. Braun increases sales — investments at a high level

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
B. Braun Melsungen AG – Key Facts
B. Braun Melsungen AG – Key Employees
B. Braun Melsungen AG – Major Products and Services
B. Braun Melsungen AG – History
B. Braun Melsungen AG – Company Statement
B. Braun Melsungen AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
B. Braun Melsungen AG – Business Description
Business Segment: B. Braun Aesculap
Overview
Performance
Business Segment: B. Braun Avitum
Overview
Performance
Key Stats
Business Segment: B. Braun Hospital Care
Overview
Performance
Business Segment: B. Braun Out Patient Market
Overview
Performance
Business Segment: Other Sales
Performance
Geographical Segment: Africa and Middle East
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe (Without Germany)
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
B. Braun Melsungen AG – Corporate Strategy
B. Braun Melsungen AG – SWOT Analysis
SWOT Analysis – Overview
B. Braun Melsungen AG – Strengths
B. Braun Melsungen AG – Weaknesses
B. Braun Melsungen AG – Opportunities
B. Braun Melsungen AG – Threats
B. Braun Melsungen AG – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
B. Braun Melsungen AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
B. Braun Melsungen AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 16, 2021: Vaccination Supplies: Warning against Fraud Attempts with Supposed B. Braun Products
Jun 05, 2020: After more than 30 years of service, Management Board Member Caroll H. Neubauer Retires from B. Braun
May 14, 2020: Aesculap wins iF DESIGN AWARD
Apr 04, 2020: Scam alert for sale of B. Braun products
Mar 27, 2020: 2019 fiscal year: B. Braun increases sales — investments at a high level
Feb 14, 2020: Scam alert for sale of B. Braun masks
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
B. Braun Melsungen AG, Key Facts
B. Braun Melsungen AG, Key Employees
B. Braun Melsungen AG, Major Products and Services
B. Braun Melsungen AG, History
B. Braun Melsungen AG, Subsidiaries
B. Braun Melsungen AG, Joint Venture
B. Braun Melsungen AG, Key Competitors
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
B. Braun Melsungen AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
B. Braun Melsungen AG, Recent Deals Summary

★海外企業調査レポート[B. Braun Melsungen AG:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enterome Bioscience SA-製薬・医療分野:企業M&A・提携分析
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • Western Areas Limited:企業の戦略・SWOT・財務分析
    Western Areas Limited - Strategy, SWOT and Corporate Finance Report Summary Western Areas Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • e.l.f. Beauty, Inc. (ELF):企業の財務・戦略的SWOT分析
    e.l.f. Beauty, Inc. (ELF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Clementia Pharmaceuticals Inc (CMTA)-製薬・医療分野:企業M&A・提携分析
    Summary Clementia Pharmaceuticals Inc (Clementia) is a biopharmaceutical company that develops and commercializes orphan drugs and therapies. The company’s palovarotene is used for treatment of muscle tissue disorders such as fibrodysplasia ossificans progressive and other diseases. Its palovarotene …
  • Lee & Man Paper Manufacturing Ltd:企業の戦略・SWOT・財務情報
    Lee & Man Paper Manufacturing Ltd - Strategy, SWOT and Corporate Finance Report Summary Lee & Man Paper Manufacturing Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • John B. Sanfilippo & Son, Inc.:企業の戦略・SWOT・財務情報
    John B. Sanfilippo & Son, Inc. - Strategy, SWOT and Corporate Finance Report Summary John B. Sanfilippo & Son, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Five Prime Therapeutics Inc (FPRX):企業の財務・戦略的SWOT分析
    Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Mitochon Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotech company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products comprise mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stroke, h …
  • Hess Corp (HES):企業の財務・戦略的SWOT分析
    Hess Corp (HES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Hafslund AS:企業の戦略・SWOT・財務情報
    Hafslund AS - Strategy, SWOT and Corporate Finance Report Summary Hafslund AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • EWE AG:石油・ガス:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • H.I.S. Co., Ltd.:戦略・SWOT・企業財務分析
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • LendingClub Corporation (LC):企業の財務・戦略的SWOT分析
    LendingClub Corporation (LC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bluefish Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Bluefish Pharmaceuticals AB (Bluefish Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes generic pharmaceuticals. The company offers products in the therapeutic areas of cardiovascular, central nervous system, gastrointestinal, diabetes, oncology, dermat …
  • Golden Ocean Group Limited:企業のM&A・事業提携・投資動向
    Golden Ocean Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Golden Ocean Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Jacobs Engineering Group Inc (JEC)-石油・ガス分野:企業M&A・提携分析
    Summary Jacobs Engineering Group Inc. (Jacobs) is a provider of technical professional services. The company offers a diverse range of technical, professional, and construction services to industrial, commercial, and governmental customers across the globe. Its service portfolio includes project; pr …
  • Independent Electricity System Operator:企業の戦略的SWOT分析
    Independent Electricity System Operator - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothe …
  • CH2M HILL Companies, Ltd.:戦略・SWOT・企業財務分析
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆